Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

29.66
Delayed Data
As of Feb 12
 +0.51 / +1.75%
Today’s Change
28.29
Today|||52-Week Range
36.69
-12.64%
Year-to-Date
AZN Regular Dividend: AZN will begin trading ex-dividend on 02/17/16 with a $0.95 dividend payable to shareholders of record as of 02/19/16.

Today’s Trading

Previous close29.15
Today’s open29.18
Day’s range29.14 - 29.68
Volume2,995,676
Average volume (3 months)3,834,686
Market cap$75.0B
Dividend yield7.92%
Data as of 4:03pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+128.05%
Earnings growth (this year)-5.77%
Earnings growth (next 5 years)+3.30%
Revenue growth (last year)-5.11%
P/E ratio44.2
Price/Sales3.48
Price/Book4.06

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co-0.15-0.21%
CELGCelgene+2.86+2.87%
ABBVAbbVie+0.40+0.77%
ABTAbbott Laboratories+0.79+2.17%
Data as of 4:02pm ET, 02/12/2016

Financials

Next reporting dateApril 29, 2016
EPS forecast (this quarter)$0.46
Annual revenue (last year)$24.7B
Annual profit (last year)$2.8B
Net profit margin11.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Pascal Soriot
Executive VP-Operations &
Information Technology
Pam P. Cheng
Corporate headquarters
London, Greater London

Forecasts

Partner Offers